Stocks and Investing Stocks and Investing
Wed, August 11, 2021
Tue, August 10, 2021

Vamil Divan Maintained (AXSM) at Strong Buy with Decreased Target to $55 on, Aug 10th, 2021


Published on 2024-10-27 17:35:51 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Mizuho, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $118 to $55 on, Aug 10th, 2021.

Vamil has made no other calls on AXSM in the last 4 months.



There are 2 other peers that have a rating on AXSM. Out of the 2 peers that are also analyzing AXSM, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vamil


  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $112 on, Thursday, June 10th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $225 on, Tuesday, April 27th, 2021

Contributing Sources